Comparing Budesonide / Formoterol / Glycopyrrolate vs Umeclidinium
| Budesonide / formoterol / glycopyrrolate | Umeclidinium |
|
|---|
| Budesonide / formoterol / glycopyrrolate | Umeclidinium |
|
|---|---|---|
|
Prescription only
Prescribed for COPD - Maintenance, COPD. Budesonide / formoterol / glycopyrrolate may also be used for purposes not listed in this medication guide. |
Prescription only
Prescribed for COPD - Maintenance, COPD. Umeclidinium may also be used for purposes not listed in this medication guide. |
Related suggestions |
| More about Budesonide / formoterol / glycopyrrolate | More about Umeclidinium | |
| Ratings & Reviews | ||
|
Budesonide / formoterol / glycopyrrolate has an average rating of 7.0 out of 10 from a total of 121 ratings on Drugs.com. 55% of reviewers reported a positive effect, while 13% reported a negative effect. |
Umeclidinium has an average rating of 4.1 out of 10 from a total of 38 ratings on Drugs.com. 29% of reviewers reported a positive effect, while 61% reported a negative effect. |
|
| Side Effects Experienced by Users Side effects are reported in Drugs.com user reviews and not clinically verified. | ||
View all Budesonide / formoterol / glycopyrrolate side effects |
View all Umeclidinium side effects |
|
| Drug Class | ||
| Generic Availability | ||
|
N/A |
N/A |
|
| Pricing and Coupons * Prices are without insurance | ||
|
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
We could not find an exact match for this medicine. Try searching the Price Guide directly. |
|
| Dosage Forms | ||
|
N/A |
N/A |
|
| Brand Names | ||
| Breztri Aerosphere | Incruse Ellipta | |
| Half Life Drug half-life is the time required for plasma concentration to reduce to half its original value. | ||
|
N/A |
11 hours |
|
| CSA Schedule 1 View glossary of CSA terms | ||
|
Not a controlled drug
Is not subject to the Controlled Substances Act. |
Not a controlled drug
Is not subject to the Controlled Substances Act. |
|
| Pregnancy Category | ||
|
Summary unavailable. See the full pregnancy warnings document. |
Category C
Risk cannot be ruled out
See the full pregnancy warnings document. |
|
| Drug Interactions | ||
|
A total of 957 drugs are known to interact with Budesonide / formoterol / glycopyrrolate:
|
A total of 103 drugs are known to interact with Umeclidinium:
|
|
| Alcohol/Food/Lifestyle Interactions | ||
|
No known alcohol/food interactions. This does not necessarily mean no interactions exist. Always consult your healthcare provider. |
||
| Disease Interactions | ||
|
||
| First Approval Date | ||
|
July 23, 2020 |
April 30, 2014 |
|
| WADA Class View classifications | ||
|
N/A |
||
| More Information | ||
| Patient Resources | ||
| Professional Resources | ||
|
N/A |
||
| Related Treatment Guide | ||
1 The Controlled Substances Act (CSA) schedule information displayed applies to substances regulated under federal law. There may be variations in CSA schedules between individual states.
See also:
Symbicort
Symbicort (budesonide and formoterol) is used to prevent bronchospasm in people with asthma or ...
Ventolin
Ventolin is used for asthma, acute, asthma, maintenance, bronchiectasis, bronchospasm prophylaxis ...
Breztri Aerosphere
Breztri (budesonide/glycopyrrolate/formoterol fumarate) is a combination inhaler that may be used ...
Ventolin HFA
Ventolin HFA (albuterol) is used to treat or prevent breathing problems in patients who have asthma ...
Dupixent
Dupixent is used to treat eczema, eosinophilic or oral-corticosteroid-dependent asthma, chronic ...
Breo Ellipta
Breo Ellipta (fluticasone and vilanterol) is used to prevent airflow obstruction or bronchospasm in ...
Spiriva
Spiriva (tiotropium) is used to prevent bronchospasm in people with bronchitis, emphysema, or COPD ...
Anoro Ellipta
Anoro (umeclidinium and vilanterol inhalation powder) is used to treat chronic obstructive ...
Xopenex
Xopenex is a short-acting bronchodilator used to treat or prevent bronchospasm in asthma and other ...
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.